ZOMEDICA PHARMA Revenue, Profits - ZOM Quarterly Income Statement

Add to My Stocks
$1.87 $0.06 (3.31%) ZOM stock closing price Sep 20, 2018 (Closing)
Fiscal year is Jan - Dec2018 Q22018 Q1
ZOMEDICA PHARMA Revenues or Net Sales
--
Cost Of Goods Sold (COGS)--
ZOMEDICA PHARMA Gross Profit
--
Research & Development Expense2.53M-
Selling General & Admin Expense1.58M1.53M
Income Before Depreciation Depletion Amortization-4.12M-2.13M
Depreciation Depletion Amortization--
Non Operating Income--
Interest Expense--
ZOMEDICA PHARMA Pretax Income
-4.14M-2.17M
Provision for Income Taxes--
MinorityInterest--
Investment Gains Losses--
Other Income--
Income Before Extraordinaries & Disc Operations-4.14M-2.17M
Extraordinary Items & Discontinued Operations--
ZOMEDICA PHARMA Profit/ Loss (Net Income)
-4.14M-2.17M
Average Shares used to compute Diluted EPS92.53M90.52M
Average Shares used to compute Basic EPS92.53M90.52M
Income Before Nonrecurring Items-4.14M-2.17M
Income from Nonrecurring Items--
ZOMEDICA PHARMA Earnings Per Share Basic Net
-0.04-0.02
ZOMEDICA PHARMA Earnings Per Share Diluted Net
-0.04-0.02
EPS Diluted Before Nonrecurring Items-0.04-0.02
Preferred Dividends Acc Pd--
Dividends Common0.000.00
Dividend Per Share Common0.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

ZOMEDICA PHARMA Income Statement - Key Financial Ratios

Dividend Yield
0%

Other Income Statements - ZOMEDICA PHARMA Industry Peers

Durect income statement, KALVISTA PHARMA income statement, Lannett Co income statement